CU-104
- Generic Name
- CU-104
Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Curacle Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT05907330
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath